How To Use HCPCS Code C7533

HCPCS code C7533 describes a specific medical procedure known as percutaneous transluminal coronary angioplasty (PTCA) with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy. This code is used to identify and bill for this particular procedure in medical coding and billing.

1. What is HCPCS C7533?

HCPCS code C7533 is a specific alphanumeric code that is used in medical coding to identify the procedure of percutaneous transluminal coronary angioplasty (PTCA) with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy. This code is used to accurately document and bill for this procedure.

2. Official Description

The official description of HCPCS code C7533 is “Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy.” The short description for this code is “Parenteral supp not othrws c.”

3. Procedure

1. The procedure of percutaneous transluminal coronary angioplasty (PTCA) with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy involves several steps.
2. First, the healthcare provider will perform a percutaneous transluminal coronary angioplasty, which is a minimally invasive procedure to open up blocked or narrowed coronary arteries.
3. During the PTCA procedure, a catheter with a small balloon at the tip is inserted into the blocked or narrowed artery.
4. The balloon is then inflated to compress the plaque or blockage against the artery walls, widening the artery and improving blood flow.
5. After the PTCA procedure, a radiation delivery device is placed transcatheterly in the coronary artery or branch.
6. This radiation delivery device is used for subsequent coronary intravascular brachytherapy, which involves the targeted delivery of radiation to the treated area to prevent restenosis (re-narrowing) of the artery.
7. The procedure is typically performed under fluoroscopic guidance and may require the use of contrast agents to visualize the coronary arteries.

4. When to use HCPCS code C7533

HCPCS code C7533 should be used when documenting and billing for the specific procedure of percutaneous transluminal coronary angioplasty (PTCA) with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy. This code is used to accurately identify and communicate the specific procedure performed.

5. Billing Guidelines and Documentation Requirements

When using HCPCS code C7533, healthcare providers need to ensure proper documentation of the procedure performed, including details of the PTCA, transcatheter placement of the radiation delivery device, and any relevant findings or complications. It is important to include supporting documentation such as procedure notes, imaging reports, and any other relevant medical records.

6. Historical Information and Code Maintenance

HCPCS code C7533 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. There have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code.

7. Medicare and Insurance Coverage

Medicare and other insurance providers may provide coverage for the procedure identified by HCPCS code C7533. The pricing indicator code for this code is 57, which indicates that it is priced by other carriers. The multiple pricing indicator code is A, which means it is not applicable as HCPCS priced under one methodology. It is important to check with the specific insurance provider for coverage and reimbursement guidelines.

8. Examples

Here are some examples of when HCPCS code C7533 should be billed:

1. A patient undergoes percutaneous transluminal coronary angioplasty (PTCA) with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy to treat a blocked major coronary artery.
2. A healthcare provider performs PTCA with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy on a patient with restenosis of a previously treated coronary artery.
3. A patient with a history of coronary artery disease undergoes PTCA with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy as a preventive measure to reduce the risk of restenosis.
4. A healthcare provider performs PTCA with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy on a patient with a single major coronary artery or branch blockage.
5. A patient with a complex coronary artery lesion undergoes PTCA with transcatheter placement of a radiation delivery device for subsequent coronary intravascular brachytherapy to improve blood flow and prevent restenosis.